U.S. Markets closed

Device Maker Microbot Medical Gives Back Gains

Adam Smith

Massachusetts-based medical device developer Microbot Medical Inc. Microbot Medical -- which specializes in so-called "micro-robotic" medical technology -- said that an institutional investor is buying 455,323 shares of its common stock at $6.50 each. The deal is slated to wrap up Wednesday, with H.C. Wainwright & Co. acting as the exclusive placement agent for the offering.